Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 7
2004 2
2006 1
2007 4
2008 4
2009 4
2010 5
2011 7
2012 10
2013 6
2014 11
2015 14
2016 12
2017 10
2018 16
2019 13
2020 17
2021 27
2022 19
2023 20
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Neuroinflammation and depression: A review.
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C, Camus V. Troubat R, et al. Among authors: camus v. Eur J Neurosci. 2021 Jan;53(1):151-171. doi: 10.1111/ejn.14720. Epub 2020 Mar 20. Eur J Neurosci. 2021. PMID: 32150310 Review.
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
Cazelles C, Belhadj K, Vellemans H, Camus V, Poullot E, Gaulard P, Veresezan L, Itti E, Becker S, Carvalho M, Dupuis J, Le Bras F, Lemonnier F, Roulin L, El Gnaoui T, Jardin F, Mounier N, Tilly H, Haioun C. Cazelles C, et al. Among authors: camus v. Leuk Lymphoma. 2021 Sep;62(9):2161-2168. doi: 10.1080/10428194.2021.1901090. Epub 2021 Mar 25. Leuk Lymphoma. 2021. PMID: 33764240
Intervention psychothérapeutique brève (activation comportementale) pour le traitement de la dépression d’intensité légère à modérée en soins primaires : proposition d’un guide pour la pratique clinique.
Sarron PY, Palma J, Lemaire M, Camus V, El-Hage W. Sarron PY, et al. Among authors: camus v. Presse Med. 2019 Feb;48(2):109-116. doi: 10.1016/j.lpm.2018.09.016. Epub 2019 Feb 13. Presse Med. 2019. PMID: 30770278 French. No abstract available.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; Amyloid Biomarker Study Group; Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinn… See abstract for full author list ➔ Jansen WJ, et al. Among authors: camus v. JAMA. 2015 May 19;313(19):1924-38. doi: 10.1001/jama.2015.4668. JAMA. 2015. PMID: 25988462 Free PMC article.
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ; Amyloid Biomarker Study Group; Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Flier WM, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Frings L, Frisoni GB, Fröhlich L, Gabryelewicz T, Gertz HJ, Gill KD, Gkatzima O, Gómez-Tortosa E, Grimmer T, Guedj E, Habeck CG, Hampel H, Handels R, Hansson O, Hausner L, Hellwig S, Heneka MT, Herukka SK, Hildebrandt H, Hodges J, Hort J, Huang CC, Iriondo AJ, Itoh Y, Ivanoiu A, Jagust WJ, Jessen F, Johannsen P, Johnson KA, Kandimalla R, Kapaki EN, Kern S, Kilander L, Klimkowicz-Mrowiec A, Klunk WE, Koglin N, Kornhuber J, Kramberger MG, Kuo HC, Van Laere K, Landau SM, Landeau B, Lee DY, de Leon M, Leyton CE, Lin KJ, Lleó A, Löwenmark M, Madsen K, Maier W, Marcusson J, Marquié M, Martinez-Lage P,… See abstract for full author list ➔ Jansen WJ, et al. Among authors: camus v. JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216. JAMA Neurol. 2022. PMID: 35099509
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).
Bachy E, Camus V, Thieblemont C, Sibon D, Casasnovas RO, Ysebaert L, Damaj G, Guidez S, Pica GM, Kim WS, Lim ST, André M, García-Sancho AM, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Re A, Gaulard P, Delfau-Larue MH, de Leval L, Meignan M, Li J, Morschhauser F, Delarue R. Bachy E, et al. Among authors: camus v. J Clin Oncol. 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. Epub 2021 Nov 29. J Clin Oncol. 2022. PMID: 34843406 Clinical Trial.
[Potentiation strategies].
Doumy O, Bennabi D, El-Hage W, Allaïli N, Bation R, Bellivier F, Holtzmann J, Bubrovszky M, Camus V, Charpeaud T, Courvoisier P, d'Amato T, Garnier M, Haesebaert F, Bougerol T, Lançon C, Moliere F, Nieto I, Richieri R, Saba G, Courtet P, Vaiva G, Leboyer M, Llorca PM, Aouizerate B, Haffen E. Doumy O, et al. Among authors: camus v. Presse Med. 2016 Mar;45(3):338-49. doi: 10.1016/j.lpm.2016.02.004. Epub 2016 Mar 10. Presse Med. 2016. PMID: 26970936 Review. French.
[Other therapeutic strategies].
Saba G, Nieto I, Bation R, Allaïli N, Bennabi D, Moliere F, Richieri R, Holtzmann J, Bubrovszky M, Camus V, Charpeaud T, Courtet P, Courvoisier P, Haesebaert F, Doumy O, El-Hage W, Garnier M, d'Amato T, Bougerol T, Lançon C, Haffen E, Llorca PM, Vaiva G, Bellivier F, Leboyer M, Aouizerate B. Saba G, et al. Among authors: camus v. Presse Med. 2016 Mar;45(3):350-9. doi: 10.1016/j.lpm.2016.02.005. Epub 2016 Mar 16. Presse Med. 2016. PMID: 26995510 Review. French.
[How to define treatment-resistant depression?].
Holtzmann J, Richieri R, Saba G, Allaïli N, Bation R, Moliere F, Nieto I, Bellivier F, Bennabi D, Bubrovszky M, Camus V, Charpeaud T, Courvoisier P, Haesebaert F, Doumy O, Courtet P, El-Hage W, Garnier M, d'Amato T, Lançon C, Leboyer M, Llorca PM, Vaiva G, Bougerol T, Aouizerate B, Haffen E. Holtzmann J, et al. Among authors: camus v. Presse Med. 2016 Mar;45(3):323-8. doi: 10.1016/j.lpm.2016.02.002. Epub 2016 Mar 9. Presse Med. 2016. PMID: 26970938 Review. French.
Mechanisms of antidepressant resistance.
El-Hage W, Leman S, Camus V, Belzung C. El-Hage W, et al. Among authors: camus v. Front Pharmacol. 2013 Nov 22;4:146. doi: 10.3389/fphar.2013.00146. Front Pharmacol. 2013. PMID: 24319431 Free PMC article. Review.
185 results